Symplocamide A as marine-derived proteasome inhibitor: a promising scaffold for targeted cancer therapy. - Dincturk HC; Bilgin AB; Köroğlu DG; Gozukirmizi CK; Ozkan G; Capanoglu E; Setzer WN; Büsselberg D; Calina D; Sharifi-Rad J (Medical oncology (Northwood, London, England), 2025)